NCT00128245View on ClinicalTrials.gov

Safety and Efficacy of Pimecrolimus Ophthalmic Suspension in Patients With Moderate to Severe Keratoconjunctivitis Sicca

PHASE2CompletedINTERVENTIONAL
Enrollment

440

Participants

Timeline

Start Date

September 30, 2004

Primary Completion Date

December 31, 2006

Study Completion Date

December 31, 2006

Conditions
Keratoconjunctivitis Sicca
Interventions
DRUG

Pimecrolimus

DRUG

Vehicle

Placebo

Trial Locations (1)

Unknown

Novartis, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY